Autres langues Forte Biosciences, Inc.

Actions

FBRX

US34962G1094

Marché Fermé - Nasdaq Autres places de cotation 22:30:00 24/04/2024			Varia. 5j.	Varia. 1 janv.
0,7199 ^USD	-2,53 %		-2,72 %	-12,39 %

18/03	Forte Biosciences, Inc. annonce ses résultats pour l'exercice clos le 31 décembre 2023	CI
05/01	Camac Partners fournit des informations aux actionnaires	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Forte Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	18/03
Forte Biosciences, Inc. Announces 2023 Results and Provides Business Update	18/03
Camac Partners Provides Information to Shareholders	05/01
Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules	01/12
Forte Biosciences, Inc. Announces Third Quarter 2023 Results and Provides Business Update	13/11
Forte Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13/11
Tocagen Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13/11
Forte Biosciences Filed a Motion to Dismiss the Amended Complaint	28/10/23
Camac Fund Files an Amended Class Action and Derivative Complaint	20/10/23
Declaration of Voting Results by Forte Biosciences	26/09/23
Declaration of Voting Results by Forte Biosciences	26/09/23
Declaration of Voting Results by Forte Biosciences	26/09/23
Declaration of Voting Results by Forte Biosciences	26/09/23
Declaration of Voting Results by Forte Biosciences	20/09/23
Forte Biosciences, Inc. Announces Directorate Appointments	20/09/23
Institutional Shareholder Services and Glass Lewis Support Camac Partners	14/09/23
ISS and Glass Lewis Recommend Forte Biosciences Stockholders Vote FOR Boardroom Change at the Company’s Upcoming Annual Meeting	14/09/23
Concerned Stockholders of Forte Biosciences and Its Independent Director Candidates Share Key Facts that Reinforce the Need for Urgent Change in the Company’s Boardroom	06/09/23
Camac Partners Shares Key Facts that Reinforce the Need for Urgent Change in Forte Biosciences?s Boardroom	06/09/23
Forte Biosciences Issues an Investor Presentation to Shareholders	01/09/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Forte Biosciences, Inc.

Actions

FBRX

US34962G1094

Autres langues

Filtres